Lantz Financial LLC
Source: SEC Form 13F · as of Mar 2026Lantz Financial LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $20.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$20.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 13,083 | $3.2M |
| PMPhilip Morris International Inc | 15,578 | $2.6M |
| GILDGILEAD SCIENCES, INC. | 16,744 | $2.3M |
| MRKMerck & Co., Inc. | 17,525 | $2.1M |
| LLYELI LILLY & Co | 1,985 | $1.8M |
| ABBVAbbVie Inc. | 7,647 | $1.7M |
| PFEPFIZER INC | 47,201 | $1.3M |
| NVSNovartis AG | 7,900 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 12,832 | $778K |
| AMGNAMGEN INC | 1,937 | $681K |
| SNYSanofi | 13,190 | $635K |
| ABTABBOTT LABORATORIES | 4,614 | $474K |
| GMOptec International, Inc. | 5,624 | $419K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,299 | $351K |
| IDXXIDEXX LABORATORIES INC /DE | 385 | $216K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,872 | $214K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.